CCL2 and neoplasm: Administration of HT29-pcDNA-EVs did not have statistical impact on neither tumour growth nor plasma MCP-1/CCL2 levels (Figure 3A,C, Table S3) within the groups of mice injected with either HT29-pcDNA cells or HT29-Snail cells.